Here is the latest stock price and chart of BAFNA PHARMA. For more details, see the BAFNA PHARMA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
Emerging Opportunity: Bluechip Bull Run
Live BSE Quotes | May 3, 2024 (Close) | ||
---|---|---|---|
Price (Rs)106.73 | Open (Rs) 106.73 | High (Rs) 106.73 | Low (Rs) 106.73 |
% Change5.00 | Volume 14,434 | Value (Rs) 1,540,540 | 52-Week H/L 125.55 / 76.50 |
Live NSE Quotes | Aug 23, 2019 (Close) | ||
---|---|---|---|
Price (Rs)3.55 | Open (Rs) 3.70 | High (Rs) 3.85 | Low (Rs) 3.55 |
% Change-4.05 | Volume 4,503 | Value (Rs) 16,686 | 52-Week H/L 21.85 / 3.55 |
Change | |||||
---|---|---|---|---|---|
1 Day 5.00% | 1 Month 20.29% | 3 Months 8.91% | 1 Year 33.41% | 5 Years (CAGR)* 67.36% | 10 Years (CAGR)* 14.50% |
* Compound Annual Growth Rate
Valuation | ||||
---|---|---|---|---|
EPS (Rs)* 4.76 | P/E Ratio (x) 22.42 | Market Cap (Rs m) 2,524.84 | P/BV (x) 3.18 | Dividend Yield (%) 0.00 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX
|
||||||
PERIOD |
BAFNA PHARMA last traded price had surged 5.0% to Rs 106.7 on the BSE. The total volume of shares traded was 0.0 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 0.2%. And the benchmark S&P BSE SENSEX was at 73,878.2 (down 1.0%).
Over the last 30 days, the BAFNA PHARMA share price is up 26.3%. And over the last one year, BAFNA PHARMA share price is up 32.5%.
The current market capitalisation of BAFNA PHARMA stands at Rs 2,524.84 m. For more information, check out the list of top 100 companies in India in terms of market cap.
As of March 2024, company promoters held 88.30% stake in BAFNA PHARMA, with no shares having been pledged. To know more, check out the latest shareholding pattern of BAFNA PHARMA.
The last traded price of BAFNA PHARMA was Rs 106.7 on the BSE, up 5.0% over the previous close. On the NSE, BAFNA PHARMA last traded price was down 4.1% at Rs 3.6.
The current market capitalisation of BAFNA PHARMA stands at Rs 2,525 m.
BAFNA PHARMA had an EPS of Rs 4.8 in the latest financial year. In the most recent quarter, the company declared an EPS of Rs -1.2.
For the financial year 2020, BAFNA PHARMA declared dividend amounting to Rs 0.0 per share. At the current price of Rs 106.7, this results in a dividend yield of 0.0%.
Based on marketcap, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks ranked by marketcap here.
Also, here's one of our more popular screens related to marketcap: India's Biggest Companies by Marketcap.
Based on sales, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks.
Curious to know which Indian companies are growing their sales at a faster rate than their peers? Check out India's Fastest Growing Companies by Sales.
Based on net profit, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks.
In case you are wondering which company logs in the biggest net profit margin in India, check this out: High Profit Margin Companies in India.
After opening the negative note, Indian share markets Slipped further as the session progressed and ended the day weak.